Ozanimod
Market Access/ News/ News/ Top stories
BMS gets FDA nod for ozanimod, but launch will be delayed
Phil Taylor
Bristol-Myers Squibb, FDA approval, multiple sclerosis, Ozanimod
0 Comment
X
BMS gets FDA nod for ozanimod, but launch will be delayed
https://pharmaphorum.com/news/bms-gets-fda-nod-for-ozanimod-but-launch-will-be-delayed/
X
Celgene gets MS blockbuster-in-waiting ozanimod back on track
https://pharmaphorum.com/news/celgene-gets-ms-blockbuster-in-waiting-ozanimod-back-on-track/
X
Ozanimod launch delayed by failures in FDA application
https://pharmaphorum.com/news/ozanimod-launch-delayed-by-failures-in-fda-application/